BROSSARD, QUEBEC — (Marketwired) — 09/25/15 — DIAGNOS inc. (“DIAGNOS” or “the Corporation”) (TSX VENTURE: ADK), a leader in the use of artificial intelligence and advanced knowledge-extraction techniques, announces voting and election results from its Annual Meeting of Shareholders (the “Meeting”) held on September 24, 2015.
Directors
The four candidates proposed by Management were elected as directors of the Corporation to hold office until the closing of the next annual meeting of the shareholders or until his successor is duly elected. These directors are Philip Renaud, Andre Larente, Lloyd Segal and Michael Singer.
Auditor
Deloitte LLP was reappointed as the independent auditor of the Corporation to hold office until the next meeting of shareholders.
Stock Option Plan (“SOP”) amendment
The proposed amendment to the SOP, pursuant to which the maximum number of common shares that may be issued under the SOP, as approved by the board of directors on August 25, 2015, be increased from 12,000,000 to 20,000,000 common shares, representing an increase of 8,000,000 common shares, was approved by a majority of disinterested shareholders.
Other Matter: Amendment of Articles – Additional Directors
An amendment to the Corporation–s articles to permit its directors to appoint one or more additional directors, who shall hold office for a term expiring not later than the close of the next annual meeting of shareholders, subject to the total number of directors so appointed not exceeding one third of the number of directors elected at the previous annual meeting of shareholders, was approved by special resolution by the shareholders present at the Meeting.
The proposed amendment to the SOP and the amendment to the Corporation–s articles are subject to final receipt of the TSX Venture Exchange approval.
About DIAGNOS
Founded in 1998, DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare and natural resources.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
Marc-Andre Massue
Vice-President Finance and Secretary
DIAGNOS Inc.
450-678-8882 ext. 235
You must be logged in to post a comment Login